Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl clinical trials

Explore recruiting newly diagnosed high intermediate and high risk diffuse large b cell lymphoma dlbcl clinical trials.

Also recruiting in Europe

Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 3, multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to R-CHOP versus R CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed diffuse large B-cell lymphoma (DLBCL) [frontMIND]

Spain, Slovakia, Italy, Czechia, Austria, Hungary +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl trials by city

Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Toronto Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Vancouver Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Montreal Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Calgary Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Edmonton Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Ottawa Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Winnipeg Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Quebec City Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Hamilton Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Kitchener Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in London Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Halifax Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in New York Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Los Angeles Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Chicago Newly Diagnosed High Intermediate And High Risk Diffuse Large B Cell Lymphoma Dlbcl in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease